Literature DB >> 28972872

Bone Mass Assessment in a Cohort of Adults With Down Syndrome: A Cross-Sectional Study.

Ramón Costa1, Rosa De Miguel1, Clara García1, Diego Real de Asúa1, Santos Castañeda2, Fernando Moldenhauer3, Carmen Suárez3.   

Abstract

Differences in bone mineral density (BMD) have been observed between adults with Down syndrome (DS) and the general population. The purpose of this article is to describe the prevalence of bone mass disorders in a cohort of adults with DS and their predisposing factors. We performed a cross-sectional study of 104 consecutively recruited adults with DS from an outpatient clinic of a tertiary care hospital in Madrid, Spain. We recorded epidemiological and anthropometric data, nutritional variables, coexisting clinical conditions, and laboratory variables. BMD was measured at the lumbar spine, total hip, and femoral neck using dual-energy X-ray absorptiometry. The prevalence of osteopenia ranged from 48% to 52%, and that of osteoporosis ranged from 19% to 22% depending on the site of measurement (femoral neck or lumbar spine, respectively). Age was the greatest risk factor associated for lower BMD, with similar bone mass accrual curve but with lower peak of BMD than the general population. We conclude that low bone mass is an extremely prevalent condition in adult patients with DS.

Entities:  

Keywords:  Down syndrome; bone metabolism; bone mineral density; osteoporosis

Mesh:

Substances:

Year:  2017        PMID: 28972872     DOI: 10.1352/1934-9556-55.5.315

Source DB:  PubMed          Journal:  Intellect Dev Disabil        ISSN: 1934-9491


  6 in total

1.  Low bone mass and impaired fracture healing in mouse models of Trisomy21 (Down syndrome).

Authors:  Kirby M Sherman; Diarra K Williams; Casey A Welsh; Alexis M Cooper; Alyssa Falck; Shannon Huggins; Rihana S Bokhari; Dana Gaddy; Kent D McKelvey; Lindsay A Dawson; Larry J Suva
Journal:  Bone       Date:  2022-06-15       Impact factor: 4.626

Review 2.  Skeletal dynamics of Down syndrome: A developing perspective.

Authors:  Jonathan M LaCombe; Randall J Roper
Journal:  Bone       Date:  2019-12-27       Impact factor: 4.398

Review 3.  Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis.

Authors:  Y Zhang; Z Tian; S Ye; Q Mu; X Wang; S Ren; X Hou; W Yu; J Guo
Journal:  Osteoporos Int       Date:  2021-08-12       Impact factor: 4.507

Review 4.  Current Analysis of Skeletal Phenotypes in Down Syndrome.

Authors:  Jared R Thomas; Randall J Roper
Journal:  Curr Osteoporos Rep       Date:  2021-04-08       Impact factor: 5.163

5.  Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome.

Authors:  John M Starbuck; Sergi Llambrich; Rubèn Gonzàlez; Julia Albaigès; Anna Sarlé; Jens Wouters; Alejandro González; Xavier Sevillano; James Sharpe; Rafael De La Torre; Mara Dierssen; Greetje Vande Velde; Neus Martínez-Abadías
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

6.  Skeletal Deficits in Male and Female down Syndrome Model Mice Arise Independent of Normalized Dyrk1a Expression in Osteoblasts.

Authors:  Jared R Thomas; Kourtney Sloan; Kelsey Cave; Joseph M Wallace; Randall J Roper
Journal:  Genes (Basel)       Date:  2021-10-28       Impact factor: 4.141

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.